Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Gum disease appears to disrupt brain activity, potentially increasing a person’s risk of cognitive decline.People with ...

The Florey Dementia Index (FDI) is valid for predicting the age of onset of mild cognitive impairment (MCI) and Alzhei ...

There are an estimated 80,000 people living with Alzheimer’s disease in Connecticut. John Scully got to know just a few of those suffering from the disease, and for those he did meet, he learned how ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...

The Tennessee Lady Volunteers are set to host its annual “We Back Pat” game at Food City Center on Thursday against ...

A new study reveals that the sleep aid Ambien (zolpidem) may increase Alzheimer’s risk by disrupting the brain's ...

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought ...

“There are things that we can do at all stages of our lives deliberately,” says Prof Schott. “It’s never too early to start ...

Topline results from a phase 2b/3 clinical trial of blarcamesine for individuals with early-stage Alzheimer’s disease showed ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...